BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 3897582)

  • 1. Comparative efficacy of "specific" potassium citrate therapy versus conservative management in nephrolithiasis of mild to moderate severity.
    Preminger GM; Harvey JA; Pak CY
    J Urol; 1985 Oct; 134(4):658-61. PubMed ID: 3897582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized double-blind study of potassium citrate in idiopathic hypocitraturic calcium nephrolithiasis.
    Barcelo P; Wuhl O; Servitge E; Rousaud A; Pak CY
    J Urol; 1993 Dec; 150(6):1761-4. PubMed ID: 8230497
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dietary treatment of urinary risk factors for renal stone formation. A review of CLU Working Group.
    Prezioso D; Strazzullo P; Lotti T; Bianchi G; Borghi L; Caione P; Carini M; Caudarella R; Ferraro M; Gambaro G; Gelosa M; Guttilla A; Illiano E; Martino M; Meschi T; Messa P; Miano R; Napodano G; Nouvenne A; Rendina D; Rocco F; Rosa M; Sanseverino R; Salerno A; Spatafora S; Tasca A; Ticinesi A; Travaglini F; Trinchieri A; Vespasiani G; Zattoni F;
    Arch Ital Urol Androl; 2015 Jul; 87(2):105-20. PubMed ID: 26150027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physiological and physiochemical correction and prevention of calcium stone formation by potassium citrate therapy.
    Pak CY; Sakhaee K; Fuller CJ
    Trans Assoc Am Physicians; 1983; 96():294-305. PubMed ID: 6679957
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term treatment of calcium nephrolithiasis with potassium citrate.
    Pak CY; Fuller C; Sakhaee K; Preminger GM; Britton F
    J Urol; 1985 Jul; 134(1):11-9. PubMed ID: 3892044
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Correction of hypocitraturia and prevention of stone formation by combined thiazide and potassium citrate therapy in thiazide-unresponsive hypercalciuric nephrolithiasis.
    Pak CY; Peterson R; Sakhaee K; Fuller C; Preminger G; Reisch J
    Am J Med; 1985 Sep; 79(3):284-8. PubMed ID: 4036979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medical management of nephrolithiasis in Dallas: update 1987.
    Pak CY
    J Urol; 1988 Sep; 140(3):461-7. PubMed ID: 3045339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of recurrent calcium stone formation with potassium citrate therapy in patients with distal renal tubular acidosis.
    Preminger GM; Sakhaee K; Skurla C; Pak CY
    J Urol; 1985 Jul; 134(1):20-3. PubMed ID: 4009822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The current role of medical treatment of nephrolithiasis: the impact of improved techniques of stone removal.
    Preminger GM; Peterson R; Peters PC; Pak CY
    J Urol; 1985 Jul; 134(1):6-10. PubMed ID: 4009825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical prevention of renal stone disease.
    Pak CY
    Nephron; 1999; 81 Suppl 1():60-5. PubMed ID: 9873216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrate and renal calculi.
    Pak CY
    Miner Electrolyte Metab; 1987; 13(4):257-66. PubMed ID: 3306318
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Citrate and renal calculi: an update.
    Pak CY
    Miner Electrolyte Metab; 1994; 20(6):371-7. PubMed ID: 7783699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of potassium citrate therapy on stone recurrence and regrowth after extracorporeal shockwave lithotripsy in children.
    Sarica K; Erturhan S; Yurtseven C; Yagci F
    J Endourol; 2006 Nov; 20(11):875-9. PubMed ID: 17144854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Citrate and renal calculi: new insights and future directions.
    Pak CY
    Am J Kidney Dis; 1991 Apr; 17(4):420-5. PubMed ID: 2008910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alkaline citrate in prevention of recurrent calcium oxalate stones.
    Berg C
    Scand J Urol Nephrol Suppl; 1990; 130():1-83. PubMed ID: 2291093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Successful treatment of hyperuricosuric calcium oxalate nephrolithiasis with potassium citrate.
    Pak CY; Peterson R
    Arch Intern Med; 1986 May; 146(5):863-7. PubMed ID: 3963975
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduction of renal stone risk by potassium-magnesium citrate during 5 weeks of bed rest.
    Zerwekh JE; Odvina CV; Wuermser LA; Pak CY
    J Urol; 2007 Jun; 177(6):2179-84. PubMed ID: 17509313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacologic treatment of calcium calculi.
    Preminger GM
    Urol Clin North Am; 1987 May; 14(2):325-33. PubMed ID: 3576853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical management to prevent recurrent nephrolithiasis in adults: a systematic review for an American College of Physicians Clinical Guideline.
    Fink HA; Wilt TJ; Eidman KE; Garimella PS; MacDonald R; Rutks IR; Brasure M; Kane RL; Ouellette J; Monga M
    Ann Intern Med; 2013 Apr; 158(7):535-43. PubMed ID: 23546565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uric acid calculi: results of conservative treatment.
    Petritsch PH
    Urology; 1977 Dec; 10(6):536-8. PubMed ID: 23599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.